DP-04
Recruiting
100 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
iCaRe2
Recruiting
999,999 enrolled
SPECIAL
Active not recruiting
14 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
Completed
135 enrolled
ELEPHAS-02
Recruiting
416 enrolled
NEUTROFLOW
Not yet recruiting
600 enrolled
TraveraRTGx
Recruiting
200 enrolled
ORACLE
Recruiting
2,020 enrolled
PARTNER
Recruiting
6,250 enrolled
Serpentine
Recruiting
1,000 enrolled
PREFER
Completed
1,429 enrolled
EVIDENT
Recruiting
600 enrolled
MOHCCN-O
Recruiting
500 enrolled
OCTANE
Recruiting
10,000 enrolled
SkinHealth
Recruiting
420 enrolled
POSITive
Recruiting
265 enrolled
A Follow-up Study of Women Evaluated and Treated for Infertility
Completed
12,193 enrolled
G-DEFINER
Completed
247 enrolled
This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
Terminated
22 enrolled
PIONEER
Unknown
1,000 enrolled
The Incidence of Breast and Other Cancers Among Female Flight Attendants
Completed
6,093 enrolled
EPR Tumor Oximetry With CE India Ink
Terminated
3 enrolled
N1
Terminated
23 enrolled
E3N
Unknown
100,000 enrolled
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
Completed
98 enrolled
TEST
Terminated
2 enrolled